Citation: | WANG Qiang-hua, PANG Qing, WANG Xue-gu, WU Hua, CHEN Hui-juan, ZHAO Wen-jun, LI Xiang. The role of PI3K/ Akt signaling pathway in upregulation of ISG15 induced by interferon 2α in hepatocellular carcinoma cells[J]. Chinese Journal of General Practice, 2021, 19(2): 182-185, 269. doi: 10.16766/j.cnki.issn.1674-4152.001762 |
[1] |
MAK L Y, CRUZ-RAMÓN V, CHINCHILLA-LÓPEZ P, et al. Global epidemiology, prevention, and management of hepatocellular carcinoma[J]. Am Soc Clin Oncol Educ Book, 2018, 38: 262-279. http://www.onacademic.com/detail/journal_1000042310209299_1fc0.html
|
[2] |
BORDEN E C. Interferons alpha and beta in cancer: therapeutic opportunities from new insights[J]. Nat Rev Drug Discov, 2019, 18(3): 219-234. doi: 10.1038/s41573-018-0011-2
|
[3] |
MARTIN-HIJANO L, SAINZ B J R. The interactions between cancer stem cells and the innate interferon signaling pathway[J]. Front Immunol, 2020, 11: 526. doi: 10.3389/fimmu.2020.00526
|
[4] |
ZHOU S, REN M, XU H, et al. Inhibition of ISG15 enhances the anti-cancer effect of trametinib in colon cancer cells[J]. Onco Targets Ther, 2019, 12: 10239-10250. doi: 10.2147/OTT.S226395
|
[5] |
YAN X, LIU X P, GUO Z X, et al. Identification of hub genes associated with progression and prognosis in patients with bladder cancer[J]. Front Genet, 2019, 10: 408. doi: 10.3389/fgene.2019.00408
|
[6] |
TECALCO-CRUZ A C, CORTÉS-GONZÁLEZ C C, CRUZ-RAMOS E, et al. Interplay between interferon-stimulated gene 15/ISGylation and interferon gamma signaling in breast cancer cells[J]. Cell Signal, 2019, 54: 91-101. doi: 10.1016/j.cellsig.2018.11.021
|
[7] |
GAO Y, YANG J, CAI Y, et al. IFN-gamma-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling[J]. Int J Cancer, 2018, 143(4): 931-943. doi: 10.1002/ijc.31357
|
[8] |
YEH Y H, HSIAO H F, YEH Y C, et al. Inflammatory interferon activates HIF-1alpha-mediated epithelial-to-mesenchymal transition via PI3K/AKT/mTOR pathway[J]. J Exp Clin Cancer Res, 2018, 37(1): 70. doi: 10.1186/s13046-018-0730-6
|
[9] |
CHANDRASHEKAR D S, BASHEL B, BALASUBRAMANYA S A H, et al. UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses[J]. Neoplasia, 2017, 19(8): 649-658. doi: 10.1016/j.neo.2017.05.002
|
[10] |
ZHU Y, SONG D, SONG Y, et al. Interferon gamma induces inflammatory responses through the interaction of CEACAM1 and PI3K in airway epithelial cells[J]. J Transl Med, 2019, 17(1): 147. doi: 10.1186/s12967-019-1894-3
|
[11] |
WAN X X, CHEN H C, KHAN M A, et al. ISG15 inhibits IFN-alpha-resistant liver cancer cell growth[J]. Biomed Res Int, 2013, 2013: 570909. http://europepmc.org/abstract/med/24024201
|
[12] |
SCHNEIDER W M, CHEVILLOTTE M D, RICE C M. Interferon-stimulated genes: a complex web of host defenses[J]. Annu Rev Immunol, 2014, 32: 513-545. doi: 10.1146/annurev-immunol-032713-120231
|
[13] |
ZHANG Y, LI X, ZHANG Y, et al. Pegylated interferon-alpha inhibits the proliferation of hepatocellular carcinoma cells by downregulating miR-155[J]. Ann Hepatol, 2019, 18(3): 494-500. doi: 10.1016/j.aohep.2018.11.007
|
[14] |
SPROOTEN J, AGOSTINIS P, GARG A D. Type I interferons and dendritic cells in cancer immunotherapy[J]. Int Rev Cell Mol Biol, 2019, 348: 217-262. http://www.sciencedirect.com/science/article/pii/S1937644819300620
|
[15] |
CHEN R H, DU Y, HAN P, et al. ISG15 predicts poor prognosis and promotes cancer stem cell phenotype in nasopharyngeal carcinoma[J]. Oncotarget, 2016, 7(13): 16910-16922. doi: 10.18632/oncotarget.7626
|
[16] |
KAUR S, SASSANO A, DOLNIAK B, et al. Role of the Akt pathway in mRNA translation of interferon-stimulated genes[J]. Proc Natl Acad Sci U S A, 2008, 105(12): 4808-4813. doi: 10.1073/pnas.0710907105
|
[17] |
TIAN J, ZHANG X, WU H, et al. Blocking the PI3K/AKT pathway enhances mammalian reovirus replication by repressing IFN-stimulated genes[J]. Front Microbiol, 2015, 6: 886. http://pdfs.semanticscholar.org/a087/143ccafb8699cca687a6548e99633a98fe21.pdf
|
[18] |
LEI H, FURLONG P J, RA J H, et al. AKT activation and response to interferon-beta in human cancer cells[J]. Cancer Biol Ther, 2005, 4(7): 709-715. doi: 10.4161/cbt.4.7.1767
|
[19] |
VINCENT E E, ELDER D J, THOMAS E C, et al. Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer[J]. Br J Cancer, 2011, 104(11): 1755-1761. doi: 10.1038/bjc.2011.132
|